Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · IEX Real-Time Price · USD
3.880
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $544.25 million as of July 22, 2024. Its market cap has increased by 254.10% in one year.
Market Cap
544.25M
Enterprise Value
489.18M
1-Year Change
254.10%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $113.10M to $544.25M, an increase of 381.21%. That is a compound annual growth rate of 34.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 544.30M | 83.14% |
| Dec 29, 2023 | 297.20M | 238.88% |
| Dec 30, 2022 | 87.70M | -49.66% |
| Dec 31, 2021 | 174.20M | -28.16% |
| Dec 31, 2020 | 242.50M | 419.27% |
| Dec 31, 2019 | 46.70M | -58.71% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 549.94M |
| Terns Pharmaceuticals | 548.79M |
| Neurogene | 548.55M |
| LENZ Therapeutics | 547.72M |
| OmniAb | 545.81M |
| Canopy Growth | 543.29M |
| PepGen | 536.50M |
| Cross Country Healthcare | 529.96M |